A detailed history of Magnolia Capital Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Magnolia Capital Management LTD holds 3,685 shares of ABBV stock, worth $618,195. This represents 0.58% of its overall portfolio holdings.

Number of Shares
3,685
Previous 3,685 -0.0%
Holding current value
$618,195
Previous $632,000 15.19%
% of portfolio
0.58%
Previous 0.53%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $240,505 - $299,293
-1,815 Reduced 33.0%
3,685 $496,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $585,200 - $664,290
5,500 New
5,500 $593,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Magnolia Capital Management LTD Portfolio

Follow Magnolia Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnolia Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Magnolia Capital Management LTD with notifications on news.